The epidemiology of inflammatory bowel disease

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Scandinavian Journal of Gastroenterology

• Publication date

  2015-05-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/00365521.2015.1014407PMID 25687629
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis.

  2015cited by this paper
• Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

  2015cited by this paper
• Risk of Cancer in Patients with Inflammatory Bowel Diseases: a Nationwide Population-Based Cohort Study with 30 Years of Follow Up

  2015influential reference
• Costs and Resource Utilization for Diagnosis and Treatment During the Initial Year in a European Inflammatory Bowel Disease Inception Cohort: An ECCO-EpiCom Study

  2015cited by this paper
• Association Between Thiopurine Use and Nonmelanoma Skin Cancers in Patients With Inflammatory Bowel Disease: A Meta-Analysis

  2014cited by this paper
• Disease Course and Surgery Rates in Inflammatory Bowel Disease: A Population-Based, 7-Year Follow-Up Study in the Era of Immunomodulating Therapy

  2014cited by this paper
• Serum inflammatory markers and risk of colorectal cancer in patients with inflammatory bowel diseases.

  2014cited by this paper
• Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature.

  2014cited by this paper
• Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation.

  2014cited by this paper
• Inflammatory bowel disease and risk of cholangiocarcinoma: evidence from a meta-analysis of population-based studies.

  2014cited by this paper
• Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.

  2014influential reference
• Inflammation and disease duration have a cumulative effect on the risk of dysplasia and carcinoma in IBD: A case–control observational study based on registry data

  2014cited by this paper
• Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III).

  2014cited by this paper
• Utilization and efficacy of internet-based eHealth technology in gastroenterology: a systematic review

  2014cited by this paper
• Association between tumor necrosis factor-α antagonists and risk of cancer in patients with inflammatory bowel disease.

  2014cited by this paper
• Distance management of inflammatory bowel disease: systematic review and meta-analysis.

  2014cited by this paper
• Inflammatory bowel disease is associated with an increased risk of melanoma: a systematic review and meta-analysis.

  2014cited by this paper
• Initial Disease Course and Treatment in an Inflammatory Bowel Disease Inception Cohort in Europe: The ECCO-EpiCom Cohort

  2014influential reference
• Non-colorectal intestinal tract carcinomas in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (II).

  2014cited by this paper
• eHealth: Individualization of Mesalazine Treatment Through a Self-managed Web-based Solution in Mild-to-moderate Ulcerative Colitis

  2014cited by this paper
• Incidence and clinical course of Crohn's disease during the first year - results from the IBD Cohort of the Uppsala Region (ICURE) of Sweden 2005-2009.

  2014cited by this paper
• Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort.

  2014cited by this paper
• Mortality and causes of death in Crohn's disease: results from 20 years of follow-up in the IBSEN study

  2013cited by this paper
• Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study.

  2013cited by this paper
• Incidence of colorectal cancer after liver transplantation for primary sclerosing cholangitis: A systematic review and meta‐analysis

  2013cited by this paper
• Crohn’s Disease and Ulcerative Colitis Are Associated With Elevated Standardized Mortality Ratios: A Meta-Analysis

  2013cited by this paper
• East–West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort

  2013influential reference
• Incidence and natural history of ulcerative colitis in the Uppsala Region of Sweden 2005-2009 - results from the IBD cohort of the Uppsala Region (ICURE).

  2013cited by this paper
• New trends in inflammatory bowel disease epidemiology and disease course in Eastern Europe.

  2013cited by this paper
• Malignancies in patients with inflammatory bowel disease: a nationwide register study in Finland

  2013cited by this paper
• The burden of inflammatory bowel disease in Europe.

  2013cited by this paper
• Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study.

  2013cited by this paper
• Trends in overall and cause-specific mortality among patients with inflammatory bowel disease from 1982 to 2010.

  2013cited by this paper
• Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies.

  2013cited by this paper
• Incidence, Presentation, and Prognosis of Small Bowel Adenocarcinoma in Patients with Small Bowel Crohn's Disease: A Prospective Observational Study

  2013cited by this paper
• Mortality in ulcerative colitis and Crohn's disease. A population-based study in Finland.

  2012cited by this paper
• E-health: Web-guided therapy and disease self-management in ulcerative colitis. Impact on disease outcome, quality of life and compliance.

  2012cited by this paper
• Has There Been a Change in the Natural History of Crohn's Disease? Surgical Rates and Medical Management in a Population-Based Inception Cohort from Western Hungary Between 1977–2009

  2012cited by this paper
• Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review.

  2012cited by this paper
• Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study

  2012cited by this paper
• Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies.

  2012cited by this paper
• Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease.

  2012cited by this paper
• eHealth: individualisation of infliximab treatment and disease course via a self‐managed web‐based solution in Crohn's disease

  2012cited by this paper
• Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years.

  2012cited by this paper
• Epidemiology of pediatric inflammatory bowel disease: A systematic review of international trends

  2011cited by this paper
• Outcomes of patients with Crohn's disease improved from 1988 to 2008 and were associated with increased specialist care.

  2011cited by this paper
• Intestinal inflammation and cancer.

  2011cited by this paper
• Inflammatory bowel disease therapies and cancer risk: where are we and where are we going?

  2011cited by this paper
• A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease.

  2011cited by this paper
• Risk of malignant lymphoma in patients with inflammatory bowel diseases: A Dutch nationwide study

  2011cited by this paper
• Incidence, disease phenotype at diagnosis, and early disease course in inflammatory bowel diseases in Western Hungary, 2002–2006

  2011influential reference
• E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided ‘Constant-care’ approach

  2010cited by this paper
• Risk of Extra-Intestinal Cancer in Inflammatory Bowel Disease: Meta-Analysis of Population-Based Cohort Studies

  2010influential reference
• Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males.

  2010cited by this paper
• Colorectal Cancer Complicating Inflammatory Bowel Disease: Similarities and Differences Between Crohn's and Ulcerative Colitis Based on Three Decades of Experience

  2010cited by this paper
• Natural history of Crohn's disease in a population-based cohort from Cardiff (1986–2003): a study of changes in medical treatment and surgical resection rates

  2010cited by this paper
• Mortality in inflammatory bowel disease in the Netherlands 1991–2002: Results of a population‐based study: The IBD South‐Limburg cohort†

  2010cited by this paper
• Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease.

  2010cited by this paper
• Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort.

  2010cited by this paper
• Inflammatory Bowel Disease in South Limburg (the Netherlands) 1991-2002: Incidence, diagnostic delay, and seasonal variations in onset of symptoms.

  2009cited by this paper
• Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.

  2009cited by this paper
• Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study)

  2009cited by this paper
• Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease.

  2009cited by this paper
• An Update on the Epidemiology of Inflammatory Bowel Disease in Asia

  2008influential reference
• Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000

  2007influential reference
• Ulcerative Colitis: Patient Characteristics May Predict 10-Yr Disease Recurrence in a European-Wide Population-Based Cohort

  2007cited by this paper
• Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study.

  2007cited by this paper
• Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study.

  2007cited by this paper
• Overall and Cause-Specific Mortality in Ulcerative Colitis: Meta-analysis of Population-Based Inception Cohort Studies

  2007cited by this paper
• INFLAMMATORY BOWEL DISEASE Crohn’s disease: increased mortality 10 years after diagnosis in a Europe-wide population based cohort

  2006cited by this paper
• Incidence and Prognosis of Colorectal Dysplasia in Inflammatory Bowel Disease: A Population‐based Study from Olmsted County, Minnesota

  2006cited by this paper
• Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940–2004

  2006cited by this paper
• Crohn's disease in Stockholm County during 1990-2001: an epidemiological update.

  2006cited by this paper
• Increasing Incidences of Inflammatory Bowel Disease and Decreasing Surgery Rates in Copenhagen City and County, 2003–2005: A Population-Based Study from the Danish Crohn Colitis Database

  2006cited by this paper
• Meta‐analysis: colorectal and small bowel cancer risk in patients with Crohn's disease

  2006cited by this paper
• Primary Sclerosing Cholangitis, Inflammatory Bowel Disease, and Colon Cancer

  2006cited by this paper
• Ulcerative colitis: no rise in mortality in a European-wide population based cohort 10 years after diagnosis

  2006cited by this paper
• Increase in incidence and prevalence of inflammatory bowel disease in northern Denmark: a population-based study, 1978–2002

  2006cited by this paper
• The Epidemiology of Inflammatory Bowel Disease in Canada: A Population-Based Study

  2006influential reference
• Increased Risk of Intestinal Cancer in Crohn's Disease: A Meta-Analysis of Population-Based Cohort Studies

  2005cited by this paper
• Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.

  2005cited by this paper
• Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine

  2005cited by this paper
• Epidemiology of inflammatory bowel disease in adults who refer to gastroenterology care in Romania: a multicentre study

  2004cited by this paper
• Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.

  2004cited by this paper
• Survival and cause-specific mortality in ulcerative colitis: follow-up of a population-based cohort in Copenhagen County.

  2003cited by this paper
• Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis.

  2002cited by this paper
• Mortality and causes of death in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark.

  2002cited by this paper
• Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease

  2001cited by this paper
• The risk of colorectal cancer in ulcerative colitis: a meta-analysis

  2001cited by this paper
• Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction?

  2001cited by this paper
• Cancer risk in patients with inflammatory bowel disease

  2001cited by this paper
• Family history as a risk factor for colorectal cancer in inflammatory bowel disease.

  2001influential reference
• Clinical course and costs of care for Crohn's disease: Markov model analysis of a population-based cohort.

  1999cited by this paper
• Ulcerative colitis. An epidemiological study based on a regional inception cohort, with special reference to disease course and prognosis.

  1999cited by this paper
• Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival.

  1998cited by this paper
• Crohn's disease--occurrence, course and prognosis. An epidemiologic cohort-study.

  1997cited by this paper
• Incidence of Crohn's disease in four counties in southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists.

  1996cited by this paper
• A population-based study of inflammatory bowel disease in Florence over 15 years (1978-92).

  1996cited by this paper
• Changes in extent of ulcerative colitis: a study on the course and prognostic factors.

  1996cited by this paper
• Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists.

  1996cited by this paper

• Development of an Evidence-based Quality Indicator Set for Patients With Inflammatory Bowel Disease in Belgium.

  2026cites this paper
• Burden of anemia in inflammatory bowel disease: A systematic review and meta-analysis

  2026cites this paper
• Conversion to open following a minimally invasive surgical attempt in inflammatory bowel disease is not associated with increased morbidity compared to a planned open approach.

  2026cites this paper
• Position statement of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis on the use of Telemedicine in Inflammatory Bowel Disease

  2025cites this paper
• Supplementation of Glucosamine Selenium Ameliorates DSS-Induced Chronic Colitis in Mice via Affecting Gut Microbiota, Inhibiting Pyroptosis and Inactivating Chemokine Signaling Pathway

  2025cites this paper
• Colon health benefits of plant-derived exosome-like nanoparticles via modulating gut microbiota and immunity

  2025cites this paper
• Therapeutic impacts of oral anti-diabetic drugs on Inflammatory Bowel Disease (IBD), a comprehensive review of clinical and preclinical studies.

  2025cites this paper
• Adherence to a Mediterranean dietary pattern is associated with biochemical remission in patients with Crohn's disease.

  2025cites this paper
• Evaluating the triglyceride-glucose index as a biomarker for inflammatory bowel disease risk: insights from a UK Biobank prospective study

  2025cites this paper
• Chlorogenic Acid Alleviates Chronic Stress-Induced Ileal Oxidative Stress and Apoptosis in Rats by Influencing Intestinal Flora and Activating Nrf2 Pathway

  2025cites this paper
• Current approaches to studying human resting-state function in inflammatory bowel disease

  2025cites this paper
• Cytomegalovirus infection in patients with active ulcerative colitis: a prospective observational study.

  2025cites this paper
• Long‐Term Risk of Inflammatory Bowel Disease With MASLD: A Large‐Scale Prospective Cohort Study in UK Biobank

  2025cites this paper
• Combined metabolomic and metagenomic analysis reveals inflammatory bowel disease diversity in pediatric and adult patients

  2025cites this paper
• Impact of Dysbiosis on Intestinal Health in Young Adults with Chronic Inflammatory Diseases

  2025cites this paper
• Impact of fatigue in Crohn's disease is negatively related to resting state functional connectivity between the superior parietal lobule and parahippocampal gyrus/hippocampus

  2025cites this paper
• A Triple Perspective on the Triple Visit: Protocol for a Mixed Methods Evaluation of the Implementation of a Pediatric Multidisciplinary Clinic Model for Inflammatory Bowel Disease

  2025cites this paper
• An Assessment of the Nutritional Status in Patients with Inflammatory Bowel Disease—A Matched-Pair Case–Control Study

  2025cites this paper
• Physical exercise as a potential adjuvant therapy: effects on inflammation and nutrition in colorectal cancer patients—a systematic review and meta-analysis

  2025cites this paper
• A scoping review on reporting of methods in DSS colitis mouse models

  2025cites this paper
• Asymptomatic Inflammatory Bowel Disease Diagnosed During Colorectal Cancer Population Screening in Catalonia: Characteristics and Natural History

  2024cites this paper
• Position statement of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis on the use of Telemedicine in Inflammatory Bowel Disease.

  2024cites this paper
• Review article: Measuring disease severity in inflammatory bowel disease – Beyond treat to target

  2024cites this paper
• Swiprosin-1 participates in the berberine-regulated AMPK/MLCK pathway to attenuate colitis-induced tight junction damage.

  2024cites this paper
• Inflammatory Bowel Disease and Cardiovascular Disease: An Integrative Review With a Focus on the Gut Microbiome

  2024cites this paper
• Associations Between ABO Blood Groups and Diseases in the Digestive System and Vein

  2024cites this paper
• Physical development and bone mineral density of children with inflammatory bowel diseases

  2024cites this paper
• Emerging Technologies in Inflammatory Bowel Disease: A Minireview on Future Treatment Modalities.

  2024cites this paper
• Causes of Colectomy in Patients with Ulcerative Colitis: Findings from an Iranian National Registry

  2024cites this paper
• Sophora japonica Extract Inhibits Ulcerative Colitis and Colitis-Associated Colon Cancer via Regulation of Lipid Metabolism

  2024cites this paper
• Evaluating the predictive effect of vitamin D on clinical outcomes of infliximab-treated Crohn’s disease patients in western China

  2024influential citation
• Effectiveness of Propolis on Experimental Colitis Model In Rats

  2024cites this paper
• Hyaluronic acid-functionalized DDAB/PLGA nanoparticles for improved oral delivery of magnolol in the treatment of ulcerative colitis.

  2024cites this paper
• Factors that Increase the Risk of Inflammatory Bowel Disease

  2024cites this paper
• Heat-Killed Saccharomyces boulardii Alleviates Dextran Sulfate Sodium-Induced Ulcerative Colitis by Restoring the Intestinal Barrier, Reducing Inflammation, and Modulating the Gut Microbiota

  2024cites this paper
• Effect of intestinal permeability and phagocytes diffusion rate on pattern structure of Crohn’s disease based on the Turing–Hopf bifurcation

  2024cites this paper
• Causal association of blood cell traits with inflammatory bowel diseases: a Mendelian randomization study

  2024cites this paper
• Evolving Landscape of Paediatric Inflammatory Bowel Disease: Insights from a Decade-Long Study in North-East Slovenia on Incidence, Management, Diagnostic Delays, and Early Biologic Intervention

  2024cites this paper
• Iron therapy supplementation in inflammatory bowel disease patients with iron deficiency anemia: findings from a real-world analysis in Italy

  2024cites this paper
• The Role of Adipose Tissue Mesenchymal Stem Cells in Colonic Anastomosis Healing in Inflammatory Bowel Disease: Experimental Study in Rats

  2023cites this paper
• Clinical Implications of Dietary Probiotic Supplement (Associated with L-Glutamine and Biotin) in Ulcerative Colitis Patients’ Body Composition and Quality of Life

  2023cites this paper
• Multiomics Strategy Reveals the Mechanism of Action and Ameliorating Effect of Deer Velvet Antler Water Extracts on DSS-Induced Colitis

  2023cites this paper
• Clinical and Diagnostic Value of Inflammatory Bowel Diseases' Serological Markers in Children (Literature Review)

  2023cites this paper
• Neuroimmune Modulation Through Vagus Nerve Stimulation Reduces Inflammatory Activity in Crohn’s Disease Patients: A Prospective Open-label Study

  2023cites this paper
• Estimation of patients affected by inflammatory bowel disease potentially eligible for biological treatment in a real-world setting.

  2023cites this paper
• Ulcerative colitis and periodontitis – a cross-sectional pilot study from a Norwegian cohort

  2023cites this paper
• Clinical and epidemiological aspects of ulcerative colitis in the Irkutsk region

  2023cites this paper
• A special polysaccharide hydrogel coated on Brasenia schreberi: preventive effects against ulcerative colitis via modulation of gut microbiota.

  2023cites this paper
• A platform to reproducibly evaluate human colon permeability and damage

  2023cites this paper
• Surgical Outcomes in 62 Patients with Ulcerative Colitis: A Retrospective, Single-Center Study from Poland

  2023cites this paper
• Advancements in Inflammatory Bowel Disease: A Narrative Review of Diagnostics, Management, Epidemiology, Prevalence, Patient Outcomes, Quality of Life, and Clinical Presentation

  2023cites this paper
• Effects of natural mono- and di-saccharide as alternative sweeteners on inflammatory bowel disease: a narrative review

  2023influential citation
• New Insights Into the Epigenetic Regulation of Inflammatory Bowel Disease

  2022cites this paper
• Quality of life in Inflammatory Bowel Diseases (IBDs) patients after surgery.

  2022cites this paper
• Retinoic Acid Signaling Is Compromised in DSS-Induced Dysbiosis

  2022cites this paper
• World mortality of ankylosing spondylitis, psoriatic arthritis and inflammatory bowel disease in 2015 and its evolution from 2001 to 2015.

  2022cites this paper
• The Short Health Scale: A Valid and Reliable Quality-of-Life Scale for Mainland Chinese Patients with Inflammatory Bowel Disease

  2022cites this paper
• [Epidemiological study on the incidence of inflammatory bowel disease in Yinzhou District, Ningbo City from 2011 to 2020].

  2022cites this paper
• Can dysplasia surveillance be better targeted in ulcerative colitis by using faecal calprotectin?

  2022cites this paper
• 8-Oxypalmatine, a novel oxidative metabolite of palmatine, exhibits superior anti-colitis effect via regulating Nrf2 and NLRP3 inflammasome.

  2022cites this paper
• Telemedicine based on patient-reported outcomes in management of patients with inflammatory bowel disease in a real-life setting – a before and after cohort study

  2022influential citation
• High incidence of inflammatory bowel disease in Northern Australia: a prospective community population‐based Australian incidence study in the Mackay‐Isaac‐Whitsunday region

  2022cites this paper
• Influence of diabetes mellitus on inflammatory bowel disease course and treatment outcomes. A systematic review with meta-analysis.

  2022cites this paper
• Periodontitis prevalence in patients with ulcerative colitis and Crohn's disease ‐ PPCC: A case–control study

  2022cites this paper
• MarvelD3 Is Upregulated in Ulcerative Colitis and Has Attenuating Effects during Colitis Indirectly Stabilizing the Intestinal Barrier

  2022cites this paper
• The effect of educational empowerment interventions on IBD patients in worldwide: A systematic review of randomized clinical trials

  2022cites this paper
• Alkaloids from Aconitum carmichaelii Alleviates DSS-Induced Ulcerative Colitis in Mice via MAPK/NF-κB/STAT3 Signaling Inhibition

  2022cites this paper
• Disparities in utilization of laparoscopic colectomies in pediatric Crohn's disease✰.

  2022cites this paper
• EXTRA-INTESTINAL MANIFESTATIONS OF CROHN DISEASE AND CHRONIC ULCERATIVE COLITIS IN THE ORAL CAVITY

  2022cites this paper
• Inflammatory Bowel Disease Therapeutics: A Focus on Probiotic Engineering

  2022cites this paper
• The First Association Study of Protein Tyrosine Phosphatase, non-receptor type 2 (PTPN2) Gene Polymorphisms in Malaysian Patients with Crohn's Disease.

  2022cites this paper
• A Prospective Questionnaire-Based Study to Evaluate Factors Affecting the Decision to Receive COVID-19 Vaccination in 267 Patients with Inflammatory Bowel Disease in Poland

  2022cites this paper
• Negative experiences with public bathrooms and chronic illness‐related shame

  2022cites this paper
• Effect of systemic ozone use on oxidative modification of lipids and proteins in the colon in experimental colitis

  2022cites this paper
• Clinical and epidemiological features of ulcerative colitis patients in Sardinia, Italy: Results from a multicenter study

  2022cites this paper
• Pleiotropic Effects of Vitamin D in Patients with Inflammatory Bowel Diseases

  2022cites this paper
• Quantitative real-time PCR analysis of bacterial biomarkers enable fast and accurate monitoring in inflammatory bowel disease

  2022cites this paper
• Strains producing different short-chain fatty acids alleviate DSS-induced ulcerative colitis by regulating intestinal microecology.

  2022cites this paper
• Global trends in intestinal flora and ulcerative colitis research during the past 10 years: A bibliometric analysis

  2022cites this paper
• Protective Effects of Grape Seed Proanthocyanidin Extract in Preventing DSS Induced Ulcerative Colitis Based on Pharmacodynamic, Pharmacokinetic and Tissue Distribution.

  2022cites this paper
• Global alteration of colonic microRNAome landscape associated with inflammatory bowel disease

  2022cites this paper
• Morphological and immunohistochemical changes in oxazolone-induced ulcerative colitis under ozone therapy

  2022cites this paper
• Impact of sociodemographic factors and screening, diagnosis, and treatment strategies on colorectal cancer mortality in Brazil: A 20-year ecological study

  2022cites this paper
• The knowledge and skills needed to perform intestinal ultrasound for inflammatory bowel diseases—an international Delphi consensus survey

  2022cites this paper
• Do Only Calcium and Vitamin D Matter? Micronutrients in the Diet of Inflammatory Bowel Diseases Patients and the Risk of Osteoporosis

  2021cites this paper
• A deeper dive into disparities in IBD: Data from the ACS NSQIP.

  2021cites this paper
• Trends in the epidemiology of inflammatory bowel disease in Colombia by demographics and region using a nationally representative claims database and characterization of inflammatory bowel disease phenotype in a case series of Colombian patients

  2021cites this paper
• Subtotal colectomy in ulcerative colitis—long term considerations for the rectal stump

  2021cites this paper
• Association Between Inflammatory Bowel Disease and Dementia: A Retrospective Cohort Study

  2021cites this paper
• Integration of eHealth Into Pediatric Inflammatory Bowel Disease Care is Safe: 3 Years of Follow-up of Daily Care

  2021cites this paper
• Current overview of opioids in progression of inflammatory bowel disease; pharmacological and clinical considerations

  2021cites this paper
• Study of microbiome changes in patients with ulcerative colitis in the Central European part of Russia

  2021cites this paper
• Real-world disease activity and sociodemographic, clinical and treatment characteristics of moderate-to-severe inflammatory bowel disease in Brazil

  2021cites this paper
• Autoimmune profile of rat blood in experimental ulcerative colitis

  2021cites this paper
• Role of Telemedicine in Inflammatory Bowel Disease: Systematic Review and Meta-analysis of Randomized Controlled Trials

  2021cites this paper
• Effectiveness and safety of acupuncture therapy for inflammatory bowel disease: a protocol of systematic review and meta-analysis

  2021cites this paper
• MicroRNA expression in inflammatory bowel disease-associated colorectal cancer

  2021cites this paper
• Mesalazine and inflammatory bowel disease - from well-established therapies to progress beyond the state of the art.

  2021cites this paper
• Symptoms of central sensitization in patients with inflammatory bowel diseases: a case-control study examining the role of musculoskeletal pain and psychological factors.

  2021cites this paper
• Revealing the Mechanism of Friedelin in the Treatment of Ulcerative Colitis Based on Network Pharmacology and Experimental Verification

  2021cites this paper